MobiusHD
Phase 2- Indications
- Heart failure, Hypertension
Company intelligence / Profile preview
Vascular Dynamics has developed the MobiusHD device, an endovascular carotid implant designed to amplify the body’s natural baroreflex mechanism and modulate autonomic nervous system activity. Preliminary feasibility studies in heart failure patients have shown promising safety and efficacy results, with improvements in clinical endpoints such as quality of life scores, six-minute walk distance, NT-proBNP levels, and left ventricular ejection fraction. The company has completed initial pilot trials and plans to expand into larger pivotal studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vascular Dynamics.